Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Ранг среди акций
#3610
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Цена акции
$3.74
Рыночная капитализация
$4.73B
Изменение (1 день)
0.74%
Изменение (1 год)
-51.90%
Страна
CN
Торговля Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Категория
Healthcare
Прибыль Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Прибыль на Jun 2026 TTM: $-68.50M
Согласно последним финансовым отчетам Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., текущая прибыль компании составляет $-68.50M. В 2023 году компания получила прибыль $196.85M, меньше, чем прибыли за 2022, которая составила $809.33M. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. с 2013 по 2026
Прибыль в конце каждого года
| Год | Прибыль | Изменить |
|---|---|---|
| 2026 (TTM) | $-68.50M | -840.89% |
| 2024 | $9.25M | -95.30% |
| 2023 | $196.85M | -75.68% |
| 2022 | $809.33M | 121.33% |
| 2021 | $365.67M | 212.48% |
| 2020 | $117.02M | 275.84% |
| 2019 | $31.14M | -26.22% |
| 2018 | $42.20M | 53.78% |
| 2017 | $27.44M | 24.77% |
| 2016 | $21.99M | 8.94% |
| 2015 | $20.19M | -6.87% |
| 2014 | $21.68M | 27.42% |
| 2013 | $17.01M | 0.00% |
Прибыль схожих компаний или конкурентов
| Компания | Прибыль | Разница в прибыли | Страна |
|---|---|---|---|
| $5.27B | -7,801.05% |
US
|
|
| $-3.09B | 4,406.84% |
US
|
|
| $-4.02B | 5,763.42% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | -2,947.84% |
NL
|
